Anatomy

PLx Pharma Inc. to Present Virtually at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Retrieved on: 
Monday, September 14, 2020
Anatomy, Organ systems, Medical specialties, Hepatotoxins, RTT, Nonsteroidal anti-inflammatory drugs, Digestive system, Abdomen, Aspirin, Ibuprofen, Pharma, Stomach

The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Companys website at www.plxpharma.com , under the Investors Relations Section.

Key Points: 
  • The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Companys website at www.plxpharma.com , under the Investors Relations Section.
  • The PLxGuard delivery system works by targeting delivery of active pharmaceutical ingredients to various portions of the gastrointestinal (GI) tract.
  • PLx believes this has the potential to improve the absorption of many drugs currently on the market or in development, and to reduce the risk of stomach erosions and ulcers associated with aspirin and ibuprofen, and potentially other drugs.
  • To learn more aboutPLx Pharma Inc. and its pipeline, please visit www.plxpharma.com .

miR Scientific's Breakthrough Sentinel Disease Management Platform Receives 2020 Innovation Award

Retrieved on: 
Monday, September 14, 2020
Anatomy, Histopathology, Prostate cancer, RTT, Prostate

NEW YORK, Sept. 14, 2020 /PRNewswire/ -- miR Scientific, LLC announced today that its disease management platform for prostate cancer has been selected as the winner in Questex's 2020 Fierce Innovation Awards Life Sciences Edition in the Medical Device Innovation category.

Key Points: 
  • NEW YORK, Sept. 14, 2020 /PRNewswire/ -- miR Scientific, LLC announced today that its disease management platform for prostate cancer has been selected as the winner in Questex's 2020 Fierce Innovation Awards Life Sciences Edition in the Medical Device Innovation category.
  • The Fierce Innovation Awards, a peer-reviewed awards program from the publisher of FierceBiotech and FiercePharma, has recognized miR Scientific for the miR Sentinel Prostate Test platform as an industry leading medical device innovation.
  • Validation data for the miR Sentinel Prostate Test were published in the September issue of The Journal of Urology .
  • miR Scientific, LLC is a healthcare company whose purpose is to transform cancer management by providing early and highly accurate detection, characterization and monitoring of disease.

Artificial Intelligence Technologies Transforming Medical Imaging - ResearchAndMarkets.com

Retrieved on: 
Monday, September 14, 2020
Technology, Health, Other Technology, Other Health, Anatomy, Medical physics, Medicine, Branches of biology, Histopathology, Medical imaging, Prostate cancer, RTT, Siemens Healthineers, Radiology, Prostate

The study was conducted by the FastMRI team, a collaborative project between Facebook's AI research team and radiologists at NYU Langone Health.

Key Points: 
  • The study was conducted by the FastMRI team, a collaborative project between Facebook's AI research team and radiologists at NYU Langone Health.
  • The FDA has approved two new artificial intelligence-based modules for the AI-RAD Companion platform from Siemens Healthineers.
  • The AI-Rad Companion Prostate MR for Biopsy Support automatically segments the prostate on MRI images and helps facilitate targeted prostate biopsies.
  • To see the full article and a list of related reports on the market, visit "Artificial Intelligence Technologies Transforming Medical Imaging"
    ResearchAndMarkets.com is the world's leading source for international market research reports and market data.

DiaMedica Announces First Patients Dosed in Diabetic Kidney Disease Cohort in Phase II REDUX CKD Clinical Study

Retrieved on: 
Monday, September 14, 2020
Health, Infectious diseases, Hospitals, Clinical trials, Pharmaceutical, Biotechnology, Kidney diseases, Medical specialties, Anatomy, Chronic kidney disease, Diabetic nephropathy, Kidney disease, Andrew S. Levey, Bardoxolone methyl, DM199, DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company developing novel treatments for chronic kidney disease, today announced dosing of the first participants in the diabetic kidney disease (DKD) cohort of the REDUX Phase II Chronic Kidney Disease (CKD) study.

Key Points: 
  • DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company developing novel treatments for chronic kidney disease, today announced dosing of the first participants in the diabetic kidney disease (DKD) cohort of the REDUX Phase II Chronic Kidney Disease (CKD) study.
  • The Phase II REDUX clinical trial is a multi-center, open-label investigation targeting 90 participants with Stage II or III CKD, who will be enrolled in three equal cohorts.
  • Secondary endpoints are focused on evaluating the potential for DM199 to positively impact the underlying disease causing each participants kidney disease.
  • DM199 is currently being studied in patients with chronic kidney disease and patients with acute ischemic stroke.

Shape Awards Theraderm Eternox® Peptide Crème "Best Iconic Moisturizer"

Retrieved on: 
Monday, September 14, 2020
Proteins, Branches of biology, Anatomy, Skin care, Ageing, Structural proteins, Keratins, Wrinkle, Theraderm, Collagen, Peptide, Skin

SPRINGDALE, Ark., Sept. 14, 2020 /PRNewswire/ -- Therapon Skin Health, the makers of the medical grade skin care line Theraderm Clinical Skin Care , is proud to announce that Theraderm's Eternox Peptide Crme was named "Best Iconic Moisturizer" in Shape Magazine's 2020 Beauty Awards .

Key Points: 
  • SPRINGDALE, Ark., Sept. 14, 2020 /PRNewswire/ -- Therapon Skin Health, the makers of the medical grade skin care line Theraderm Clinical Skin Care , is proud to announce that Theraderm's Eternox Peptide Crme was named "Best Iconic Moisturizer" in Shape Magazine's 2020 Beauty Awards .
  • With a thirty-year history, scientifically backed results and 31 patents on its proprietary Soluble Keratin Peptide technology, Eternox is recognized for its efficacy, innovation and outstanding healthy aging properties.
  • Lightweight, yet hydrating, Eternox has a luxurious feel and is clinically proven to decrease the appearance of lax neck skin while reducing facial wrinkles.
  • The backbone of the Eternox formula are Soluble Keratin Peptides, active molecules that cause rapid rebuilding of collagen.

Haoma Medica Announces Plenary Presentation for NaQuinate, a Potential Novel Treatment for Osteoporosis, at ASBMR 2020 Annual Meeting

Retrieved on: 
Friday, September 11, 2020
Anatomy, Skeletal system, Organ systems, Bone, Bones, Connective tissue, Osteopathies, Osteoporosis, Long bone, Trabecula

The bone studied here was the tibia in the leg, one of the largest bones in the body and where cortical bone is the core component.

Key Points: 
  • The bone studied here was the tibia in the leg, one of the largest bones in the body and where cortical bone is the core component.
  • Cortical bone is the dense outer shell of bone that forms a protective layer around the internal cavity.
  • Osteoporosis results in bone loss and changes in bone quality and strength that occurs through the normal aging process leading to fragile bones.
  • Haoma Medica Ltd is a clinical-stage biotechnology company focused on the development of therapeutics to maintain bone and vascular health.

Haoma Medica Announces Plenary Presentation for NaQuinate, a Potential Novel Treatment for Osteoporosis, at ASBMR 2020 Annual Meeting

Retrieved on: 
Friday, September 11, 2020
Anatomy, Skeletal system, Organ systems, Bone, Bones, Connective tissue, Osteopathies, Osteoporosis, Long bone, Trabecula

The bone studied here was the tibia in the leg, one of the largest bones in the body and where cortical bone is the core component.

Key Points: 
  • The bone studied here was the tibia in the leg, one of the largest bones in the body and where cortical bone is the core component.
  • Cortical bone is the dense outer shell of bone that forms a protective layer around the internal cavity.
  • Osteoporosis results in bone loss and changes in bone quality and strength that occurs through the normal aging process leading to fragile bones.
  • Haoma Medica Ltd is a clinical-stage biotechnology company focused on the development of therapeutics to maintain bone and vascular health.

Worldwide Depilatory Products Industry to 2025 - by Type, Application, Sales Channel & Geography - ResearchAndMarkets.com

Retrieved on: 
Friday, September 11, 2020
Cosmetics, Retail, Cosmetics, Dermatology, Hair removal, Human hair, Laser medicine, Plastic surgery, Market, Organic food, Medical specialties, Aesthetics, Anatomy

The "Depilatory Products Market - Forecasts from 2020 to 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Depilatory Products Market - Forecasts from 2020 to 2025" report has been added to ResearchAndMarkets.com's offering.
  • Rising disposable incomes and living standards coupled with increasing urbanization are significantly driving the market growth of depilatory products globally.
  • Growing working women population with a busy lifestyle is further accelerating the demand for convenient grooming products, thereby driving the global depilatory products market growth.
  • Rising awareness about depilatory products infused with organic and natural ingredients is also encouraging market players to launch new products, thus positively impacting the market growth of depilatory products.

BioLife Plasma Services Announces Opening of First Plasma Collection Center in Metropolitan Detroit

Retrieved on: 
Friday, September 11, 2020
Biotechnology, Pharmaceutical, Health, Life sciences, Anatomy, Body fluids, Transfusion medicine, Hematology, Blood products, Blood, Blood plasma, Biopharmaceutical, Plasma, BioLife Plasma Services, Takeda Pharmaceutical Company Limited

BioLife Plasma Services, part of the global biopharmaceutical company Takeda Pharmaceutical Company Limited, today announced the opening of a new plasma collection center in Warren to collect standard plasma from healthy donors.

Key Points: 
  • BioLife Plasma Services, part of the global biopharmaceutical company Takeda Pharmaceutical Company Limited, today announced the opening of a new plasma collection center in Warren to collect standard plasma from healthy donors.
  • Plasma is a lifeline for thousands of people with rare, chronic and complex diseases, and we are excited to open the first BioLife plasma collection center in the metropolitan Detroit area.
  • All donors will need to wear a mask or other cloth face covering inside a BioLife Plasma center.
  • BioLife Plasma Services is an industry leader in the collection of high-quality plasma that is processed into life-saving plasma-based therapies.

Clearside Biomedical’s Oncology Licensing Partner Doses First Patient in its Phase 2 Study in Patients with Choroidal Melanoma Using SCS Microinjector® for Suprachoroidal Delivery

Retrieved on: 
Friday, September 11, 2020
Visual system, Anatomy, Vision, Ophthalmology, Eye color, Melanoma, Uveal melanoma, Eye neoplasm, Choroid, Retina, Suprachoroidal drug delivery

Aura is using Clearsides SCS Microinjector to deliver AU-011 into the suprachoroidal space (SCS).

Key Points: 
  • Aura is using Clearsides SCS Microinjector to deliver AU-011 into the suprachoroidal space (SCS).
  • Auras preclinical data on suprachoroidal injection of AU-011 presented at the Association for Research in Vision and Ophthalmology conference can be accessed here .
  • Choroidal melanoma is a rare and aggressive type of eye cancer and is the most common primary intraocular tumor in adults.
  • Clearsides proprietary SCS Microinjector targets the suprachoroidal space (SCS) and offers unique access to the macula, retina and choroid where sight-threatening disease often occurs.